Independent Review Consulting (IRC) an independent Institutional Review Board (IRB) founded in 1984 announced that it has entered into a preliminary agreement to merge with the Ethical Review Committee (ERC), another central IRB providing reviews of research on behalf of subject safety since 1988. Erica Heath, founder of Independent Review Consulting (IRC), accredited by the Association for the Accreditation of Human Research Protection Program, Inc. (AAHRPP) and located in Northern California is in talks with Terri Majors, President of the Ethical Review Committee (ERC) in Missouri. Under the terms of the proposed merger, the two organizations will begin implementing an integration plan immediately while they continue to operate as their respective organizations. The first phase of the plan will be the formation of Ethical and Independent Review Services (E&I), a new Limited Liability Corporation to provide management services for both entities. Both companies have experience in the review of late-stage, multi- center trials. While IRC specializes in medical devices and federally funded studies, ERC has developed processes specializing in efficient turn-around of large, late-stage multi-center trials.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.